Athersys Company
Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications.
Technology:
COVID, Stem cell therapy
Industry:
Cell Therapy, Public
Headquarters:
Cleveland, Ohio, United States
Founded Date:
1995-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
11
Total Funding:
205200002
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-11-09
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership